v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2020   212,948        
Beginning balance at Jan. 31, 2020 $ 742,607 $ 106 $ 1,378,479 $ (637,487) $ 1,009 $ 500
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   4,689        
Issuance of common stock upon exercise of options 16,601 $ 4 16,597      
Issuance of common stock under RSU release (in shares)   992        
Issuance of common stock under employee stock purchase plan (in shares)   565        
Issuance of common stock under employee stock purchase plan 17,284   17,284      
Vesting of early exercised stock options 1,722   1,722      
Stock-based compensation expense 61,351   61,351      
Capitalized stock-based compensation 890   890      
Net loss (49,096)     (49,096)    
Non-controlling interest 550         550
Other comprehensive income (loss) 106       106  
Ending balance (in shares) at Jul. 31, 2020   219,194        
Ending balance at Jul. 31, 2020 792,015 $ 110 1,476,323 (686,583) 1,115 1,050
Beginning balance (in shares) at Apr. 30, 2020   215,505        
Beginning balance at Apr. 30, 2020 753,153 $ 108 1,409,758 (656,709) (1,004) 1,000
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   2,633        
Issuance of common stock upon exercise of options 10,208 $ 2 10,206      
Issuance of common stock under RSU release (in shares)   491        
Issuance of common stock under employee stock purchase plan (in shares)   565        
Issuance of common stock under employee stock purchase plan 17,284   17,284      
Vesting of early exercised stock options 849   849      
Stock-based compensation expense 37,713   37,713      
Capitalized stock-based compensation 513   513      
Net loss (29,874)     (29,874)    
Non-controlling interest 50         50
Other comprehensive income (loss) 2,119       2,119  
Ending balance (in shares) at Jul. 31, 2020   219,194        
Ending balance at Jul. 31, 2020 792,015 $ 110 1,476,323 (686,583) 1,115 1,050
Beginning balance (in shares) at Jan. 31, 2021   223,724        
Beginning balance at Jan. 31, 2021 $ 871,874 $ 112 1,598,259 (730,116) 2,319 1,300
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 1,761 1,761        
Issuance of common stock upon exercise of options $ 10,216 $ 2 10,214      
Issuance of common stock under RSU release (in shares)   1,921        
Issuance of common stock under employee stock purchase plan (in shares)   689        
Issuance of common stock under employee stock purchase plan 27,452   27,452      
Issuance of common stock upon exercise of options (in shares)   57        
Vesting of early exercised stock options 1,594   1,594      
Stock-based compensation expense 129,010   129,010      
Capitalized stock-based compensation 4,547   4,547      
Fair value of replacement equity awards attributable to pre-acquisition service 4,011   4,011      
Net loss (140,189)     (142,367)   2,178
Non-controlling interest 3,655         3,655
Other comprehensive income (loss) (769)       (769)  
Ending balance (in shares) at Jul. 31, 2021   228,152        
Ending balance at Jul. 31, 2021 911,401 $ 114 1,775,087 (872,483) 1,550 7,133
Beginning balance (in shares) at Apr. 30, 2021   225,743        
Beginning balance at Apr. 30, 2021 853,397 $ 113 1,662,199 (815,165) 2,117 4,133
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   992        
Issuance of common stock upon exercise of options 6,462 $ 1 6,461      
Issuance of common stock under RSU release (in shares)   728        
Issuance of common stock under employee stock purchase plan (in shares)   689        
Issuance of common stock under employee stock purchase plan 27,452   27,452      
Vesting of early exercised stock options 797   797      
Stock-based compensation expense 75,364   75,364      
Capitalized stock-based compensation 2,814   2,814      
Net loss (57,318)     (57,318)    
Non-controlling interest 3,000         3,000
Other comprehensive income (loss) (567)       (567)  
Ending balance (in shares) at Jul. 31, 2021   228,152        
Ending balance at Jul. 31, 2021 $ 911,401 $ 114 $ 1,775,087 $ (872,483) $ 1,550 $ 7,133